The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.

After hours: September 20 at 7:59 PM EDT Loading Chart for ABBV ...

After hours: September 20 at 6:32 PM EDT Loading Chart for DRUG ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

To sign up for Becker's GI & Endoscopy E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you ...

After hours: 20 September at 7:59 pm GMT-4 ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...